Third-Party Credentials For Selecting The Best DCT Platform Partner

Decentralized clinical trials (DCTs) are becoming one of the most dynamic areas of recovery and growth for the life sciences industry. The potential to bring trials out of the clinic and to geographically dispersed patients is a key mitigator against disruptions and maximizes the potential for trial success irrespective of environmental factors. While there has been significant DCT information in the marketplace for some time, recently market researchers have begun to quantify offerings and provide pharmaceutical companies ways to evaluate partners as they shift their business models towards a decentralized approach.